Ritter Pharmaceuticals Inc (NASDAQ:RTTR) was the target of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 708,100 shares, a growth of 534.5% from the December 31st total of 111,600 shares. Based on an average daily trading volume, of 2,160,000 shares, the days-to-cover ratio is currently 0.3 days. Approximately 7.7% of the shares of the stock are short sold.
Shares of Ritter Pharmaceuticals stock remained flat at $$0.20 during midday trading on Friday. The company had a trading volume of 2,334,905 shares, compared to its average volume of 7,515,342. The company has a market capitalization of $1.98 million, a price-to-earnings ratio of -0.07 and a beta of 1.01. Ritter Pharmaceuticals has a 1-year low of $0.15 and a 1-year high of $1.35. The firm has a 50 day simple moving average of $0.19 and a 200 day simple moving average of $0.49.
Ritter Pharmaceuticals (NASDAQ:RTTR) last issued its quarterly earnings data on Wednesday, November 13th. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.23).
About Ritter Pharmaceuticals
Ritter Pharmaceuticals, Inc develops and sells novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which has completed Phase 2b clinical trial for the reduction of symptoms associated with lactose intolerance.
Receive News & Ratings for Ritter Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ritter Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.